您的当前位置:首页 > 行业数据 > 戈利昔替尼与已获批竞品安全性对比
图片属性
图片格式:PNG 图片大小:173KB 图片尺寸:1193*707
同报告图片
 / 4
戈利昔替尼与已获批竞品安全性对比_第1页
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
戈利昔替尼与已获批竞品安全性对比_第2页
戈利昔替尼与已获批竞品安全性对比_第3页
fCDkuq7ngrkxIHwg5Lqu54K5MiB8IOS6rueCuTMgfAp8LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18Cnwg6Z225ZCR5YyF5ousRUdGUiBFeG9uMjBpbnPnqoHlj5jlnKjlhoXnmoTlpJrnp41FR0ZS56qB5Y+Y5Lqa5Z6LIHwg5L+d55WZ5a+5RUdGUuaVj+aEn+eqgeWPmOWPilQ3OTBN56qB5Y+Y55qE5oqX6IK/55ik5rS75oCnIHwg5pS55ZaE6I2v5Luj5Yqo5Yqb5a2m77yM5Lq65L2T5Y2K6KGw5pyf6ZW/6L6+57qmNTDlsI/ml7bvvIzmr4/ml6XkuIDmrKHlj6PmnI3lrp7njrDmjIHnu63nqLPlrprmipHliLYgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76ISJ6YCa77yM5Zu95YWD6K+B5Yi456CU56m25omA
戈利昔替尼与已获批竞品安全性对比_第4页
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
戈利昔替尼与已获批竞品安全性对比_第5页
fCDlubTku70gfCDlhajnkIMgRUdGUiBleDIwaW5zIE5TQ0xDIOaWsOWPkeaCo+iAheaVsOmHjyAo5Y2D5Lq6KSB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMTUgfCA1Ny4zICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDE2IHwgNTguOSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxNyB8IDYwLjYgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTggfCA2Mi4zICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDE5IHwgNjQuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMEUgfCA2NS45ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIxRSB8IDY3LjcgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjJFIHwgNjkuNiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyM0UgfCA3MS41ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI0RSB8IDczLjUgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjVFIHwgNzUuNiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyNkUgfCA3Ny42ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI3RSB8IDc5LjYgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjhFIHwgODEuNyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyOUUgfCA4My44ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDMwRSB8IDg2LjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya6L+q5ZOy5Yy76I2v5oub6IKh6K+05piO5Lmm5byV55So5byX6Iul5pav54m55rKZ5Yip5paH5pWw5o2u77yM5YmN55675Lqn5Lia56CU56m26Zmi5pW055CG44CC
所属报告: 迪哲医药-公司深度报告:小分子创新能力突出商业化前景良好-250617(24页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠